Discover
TPST
Tempest Therapeutics, Inc.
0.62
2 x 0.56
2 x 1.03
bid
ask
-
0.01
1.70%
2 @ 07:28 PM
0.63 +0.01 (0.91%)
| Ytd | -78.25% | |
| 1y | -94.37% |
0.62
day range
0.67
0.62
52 week range
11.09
| Open | 0.67 | Prev Close | 0.64 | Low | 0.62 | High | 0.67 | Mkt Cap | 10.54M |
| Vol | 67.43K | Avg Vol | 2.59M | EPS | -3.93 | P/E | N/A | Forward P/E | -0.61 |
| Beta | -2.78 | Short Ratio | 0.39 | Inst. Own | 23.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 0.93 | 200-d Avg | 1.63 | 1yr Est | 18.75 |
| Income Statement | |||
| Operating Expenses | 5.25M | ||
| Research and Development Expense | 1.82M | ||
| Selling, General and Administrative Expense | 3.43M | ||
| Operating Income | -5.25M | ||
| Net Income | -5.24M | ||
| Net Income Common Stock | -5.24M | ||
| Net Income Common Stock (USD) | -5.24M | ||
| Consolidated Income | -5.24M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -5.24M | ||
| Earning Before Interest & Taxes (USD) | -5.24M | ||
| Weighted Average Shares | 15.22M | ||
| Weighted Average Shares Diluted | 15.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 779.00K | ||
| Cash and Equivalents (USD) | 779.00K | ||
| Current Assets | 1.70M | ||
| Property, Plant & Equipment Net | 7.44M | ||
| Total Assets | 9.63M | ||
| Debt Current | 1.29M | ||
| Total Debt | 7.56M | ||
| Current Liabilities | 4.45M | ||
| Debt Non-Current | 6.27M | ||
| Total Liabilities | 10.72M | ||
| Accumulated Retained Earnings (Deficit) | -275.32M | ||
| Shareholders Equity | -1.09M | ||
| Shareholders Equity (USD) | -1.09M | ||
| Assets Non-Current | 7.94M | ||
| Total Debt (USD) | 7.56M | ||
| Liabilities Non-Current | 6.27M | ||
| Trade and Non-Trade Payables | 2.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 359.00K | ||
| Net Cash Flow from Financing | 1.75M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.03M | ||
| Issuance (Purchase) of Equity Shares | 1.75M | ||
| Net Cash Flow from Operations | -2.78M | ||
| Share Based Compensation | -117.00K | ||